Pre- and Post-Operative Effects of Upper Extremity Aerobic Exercise in Mobility, Haemostatic Balance, and Mortality- and Morbidity-related Biomarkers in Hip Fracture Patients: A Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hip Fractures
- Sponsor
- National and Kapodistrian University of Athens
- Enrollment
- 116
- Locations
- 1
- Primary Endpoint
- Six Minute Walk Test (6MWT)
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The purposes of this study are to determine the benefits of a pre-operative aerobic exercise program and an 8-week postoperative aerobic exercise program with a portable upper extremity cycle-ergometer in patients with hip fracture.
Detailed Description
Hip fracture is one of the primary causes of significant morbidity in those over than 65 years old. Hip fracture is also among the top ten causes of loss of disability-adjusted life years in elderly. For the year 2020, in terms of the percentage of population over 80 years, Greece was second among the countries of the European Union, with this age group constituting 7.2% of its total population. In Greece, between 1977 and 2007, hip fractures doubled, with the annual impact rising to 343.96 per 100,000 inhabitants. For this population, a critical part of management is physical activity and exercise prescription both to prevent complications and to enhance rehabilitation after surgery. Postoperative (post-discharge) aerobic exercise programs of moderate intensity have already been used in patients with hip fracture proving its safety and positive effect in a variety of outcomes, such as aerobic capacity and quality of life. It is well established that these patients do not meet the minimum least amount of activity that should be done per week, based on Guidelines for Physical Activity by the World Health Organization neither during their hospitalization nor during their later life in the community. Also, although most Clinical Guidelines recommend a surgical management within 48 hours after hip trauma, there are many patient and system factors which can contribute to delayed surgery, such as surgical readiness, available resources, prioritisation and out-of-hours admission. In terms of pre-operative exercise program, the investigators hypothesize that it will reduce surgical stress through the body's better response to lactate accumulation and the acute physiological effects on the patient's hematopoietic activity and hemostatic profile. Moderate intensity exercise will reduce platelet hyperactivity, increase fibrinolytic activity and reduce coagulation factors. In this more favorable environment, the immediate postoperative recovery of basic mobility can be accelerated. Regarding the post-operative exercise program, the investigators hypothesize that it will improve the independence and function of the lower extremity by increasing the cardiopulmonary capacity, while the improvement of the nutritional factors (albumin and pre-albumin) through the post-training protein synthesis will also contribute to this. Apart from primary and secondary outcomes, at baseline the investigators will also evaluate the following: demographics; characteristics about the fracture and upcoming surgery, such as the type of fracture and the surgical procedure; New Mobility Score (NMS) to define the prefracture functional level; Addenbrooke's Cognitive Examination - III (ACE-III) to define the cognitive status. The power analysis for the selection of the sample size for the postoperative program in the change of the 6-Minute Walk Test (primary outcome) after the completion of the program, in the 8 weeks postoperatively, was performed for significance level α = 0.05 and power = 90%.The investigators' assumption for power analysis stands to find a difference of 50 meters between the groups. Considering that the ratio between the groups will be 1: 1, the required sample size is 96 patients (48 in each group). Adding a drop-out rate of 20%, required sample size is defined in 116 patients (58 in each group). About the other primary outcome (postoperative 3-day Cumulated Ambulation Score - CAS), the investigators' power analysis revealed a required sample size of 80 patients, based on the assumptions of 2.4 points difference between the groups, α = 0.05 and power = 90%. In statistical analysis, only patients who completed at least a 3 days of preoperative program will be included.
Investigators
Panagiotis Koulouvaris
MD, Assistant Professor, 1st Department of Orthopaedic Surgery, National and Kapodistrian University of Athens
National and Kapodistrian University of Athens
Eligibility Criteria
Inclusion Criteria
- •Age: 65 years old and older
- •Unilateral proximal femoral fracture/hip fracture (intertrochanteric or neck fracture)
- •Ambulatory patients before fracture (with or without aid assistance)
- •Agreed to participate and signed consent form
Exclusion Criteria
- •Pathological fractures (under musculoskeletal oncology)
- •Severe neuropsychiatric disorder (eg severe psychiatric disorder, dementia, etc.) to the extent that the researcher deems the patient incompetent or likely unable to remain compliant with the follow-up
- •Unable to implement the exercise program due to underlying pathology or disability in the upper extremities
- •More than one fracture
- •Severe and / or unstable cardiovascular disease \[e.g. congenital heart disease, uncontrolled severe hypertension (systolic blood pressure ≥ 180 mmHg and / or diastolic blood pressure ≥ 120 mmHg), unstable angina\]
- •Neurological or other conditions that significantly impair function and independence (eg stage 3-5 Parkinson's disease according to Hoehn and Yahr, advanced Multiple Sclerosis, severe arthritis of degenerative or rheumatic etiology)
- •Severe metabolic bone disease (eg Paget's disease, renal bone disease, osteomalacia), excluding osteoporosis
- •Active deadly aggressive disease (eg end-stage cancer with an estimated survival expectancy of less than 6 months)
- •Unable to understand the consent document and / or protocol instructions
- •Refusal to participate in the research
Outcomes
Primary Outcomes
Six Minute Walk Test (6MWT)
Time Frame: 8 weeks post-operatively
The 6MWT is a sub-maximal exercise test that is used to determine aerobic capacity and endurance.
Cumulated Ambulation Score
Time Frame: Total 3-day Cumulated Ambulation Score post-operatively.
The Cumulated Ambulation Score (CAS) is a reliable and valid instrument for assessing patients' basic mobility (getting in and out of bed, sit-to-stand from a chair, and walking), in orthopaedic wards. The minimum value is 0 and maximum 3 per day. The total 3-day CAS has a better prognostic value than the 1-day CAS, and is based on the sum score of the first three post-operative days, with a minimum value being 0 and maximum 9, for the total 3-day CAS, with a higher score means better outcome.
Secondary Outcomes
- Lower Extremity Functional Scale(At admission (for pre-operative status) and 4, 8, 26 & 52 weeks post-operatively (for current status))
- Lactate levels(Day 0 (at admission), Intraoperatively (at the beginning, 30 minutes later, and at the end of the surgery), & 12h postoperatively)
- Albumin levels(First day of admission, one day before surgery, 3 days, 4, 8, 26 & 52 weeks post-operatively)
- Cumulated Ambulation Score(4 weeks post-operatively)
- Six Minute Walk Test (6MWT)(4, 26 & 52 weeks post-operatively)
- Timed-Up & Go(4, 8, 26 & 52 weeks post-operatively)
- Modified Harris Hip Score(At admission (for pre-operative status) and 4, 8, 26 & 52 weeks post-operatively (for current status))
- Tissue plasminogen activator(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- Plasminogen activator inhibitor-1(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- Thrombin-Antithrombin Complex(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- Endogenous Thrombin Potential(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- Fibrinogen plasma levels(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- D-Dimers plasma levels(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- Thrombomodulin plasma levels(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- Transfusion requirements (litre)(Post-operative day 1, 2 and 3)
- Re-admission(4, 8, 26 & 52 weeks post-operatively)
- Haemostatic profile using ROTEM(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- von Willebrand factor (VWF); VWF:Antigen and VWF:Activity plasma levels(First day of admission, one day before surgery, 3 days, 1, 4, 8, 26 & 52 weeks post-operatively)
- Deep vein thrombosis & Pulmonary embolism (DVT & PE)(4, 8, 26 & 52 weeks post-operatively)
- All-cause mortality(4, 8, 26 & 52 weeks post-operatively)